NCT07005323View on ClinicalTrials.gov

Progression Suppression and Retinal Regression in VEGF-resistant AMD

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 12, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Neovascular Age-related Macular Degeneration (AMD)
Interventions
PROCEDURE

Pars plana vitrectomy

One sheet of PAL-222 is implanted into the subretinal space of either of eyes through pars plana vitrectomy.

Trial Locations (1)

755-8505

RECRUITING

Yamaguchi University Hospital, Ube

Sponsors
All Listed Sponsors
lead

PharmaBio Corporation

INDUSTRY